{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:37:31Z","timestamp":1784907451635,"version":"3.55.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1097\/bor.0b013e3283585731","type":"journal-article","created":{"date-parts":[[2012,9,27]],"date-time":"2012-09-27T22:10:34Z","timestamp":1348783834000},"page":"609-615","source":"Crossref","is-referenced-by-count":11,"title":["Update"],"prefix":"10.1097","volume":"24","author":[{"given":"Rawad","family":"Nasr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik J.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210128","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.rdc.2011.01.002","article-title":"Polymyositis and dermatomyositis: pathophysiology.","volume":"37","author":"Nagaraju","year":"2011","journal-title":"Rheum Dis Clin North Am"},{"key":"R2-5-20210128","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0960-8966(94)90044-2","article-title":"Coxsackie B1 virus-induced murine myositis: relationship of disease severity to virus dose and antiviral antibody response.","volume":"4","author":"Jongen","year":"1994","journal-title":"Neuromuscul Disord"},{"key":"R3-5-20210128","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1172\/JCI113098","article-title":"Coxsackievirus B 1-induced polymyositis. Lack of disease expression in nunu mice.","volume":"80","author":"Ytterberg","year":"1987","journal-title":"J Clin Invest"},{"key":"R4-5-20210128","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jaut.1994.1057","article-title":"Coxsackie B1 virus-induced murine myositis: a correlative study of muscular lesions and serological changes.","volume":"7","author":"Jongen","year":"1994","journal-title":"J Autoimmun"},{"key":"R5-5-20210128","doi-asserted-by":"crossref","first-page":"9209","DOI":"10.1073\/pnas.97.16.9209","article-title":"Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies.","volume":"97","author":"Nagaraju","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R6-5-20210128","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.2353\/ajpath.2009.090196","article-title":"Overexpression of MHC class I heavy chain protein in young skeletal muscle leads to severe myositis: implications for juvenile myositis.","volume":"175","author":"Li","year":"2009","journal-title":"Am J Pathol"},{"key":"R7-5-20210128","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/eji.200737882","article-title":"Endoplasmic reticulum stress and the unfolded protein response are linked to synergistic IFN-beta induction via X-box binding protein 1.","volume":"38","author":"Smith","year":"2008","journal-title":"Eur J Immunol"},{"key":"R8-5-20210128","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4269\/ajtmh.2008.79.133","article-title":"An animal model for studying the pathogenesis of chikungunya virus infection.","volume":"79","author":"Ziegler","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"R9-5-20210128","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/infdis\/jir470","article-title":"Protection from arthritis and myositis in a mouse model of acute chikungunya virus disease by bindarit, an inhibitor of monocyte chemotactic protein-1 synthesis.","volume":"204","author":"Rulli","year":"2011","journal-title":"J Infect Dis"},{"key":"R10-5-20210128","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/rheumatology\/keg427","article-title":"International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease.","volume":"43","author":"Isenberg","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"R11-5-20210128","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/rheumatology\/keg403","article-title":"Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis.","volume":"42","author":"Ruperto","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"R13-5-20210128","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/ard.2010.141051","article-title":"Serum levels of interferon alpha do not correlate with disease activity in patients with dermatomyositispolymyositis.","volume":"70","author":"Krol","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R14-5-20210128","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1002\/art.27465","article-title":"Expression of Toll-like receptor 3 and Toll-like receptor 7 in muscle is characteristic of inflammatory myopathy and is differentially regulated by Th1 and Th17 cytokines.","volume":"62","author":"Tournadre","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R15-5-20210128","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/art.30349","article-title":"Autoantibodies to survival of motor neuron complex in patients with polymyositis: immunoprecipitation of D, E, F, and G proteins without other components of small nuclear ribonucleoproteins.","volume":"63","author":"Satoh","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R16-5-20210128","doi-asserted-by":"crossref","first-page":"R111","DOI":"10.1186\/ar3836","article-title":"Resistin in idiopathic inflammatory myopathies.","volume":"14","author":"Filkova","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"R17-5-20210128","first-page":"154","article-title":"Expression of B7-homolog 1 in Polymyositis.","volume":"41","author":"Xiaoyu","year":"2011","journal-title":"Ann Clin Lab Sci"},{"key":"R18-5-20210128","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1093\/rheumatology\/ker218","article-title":"The metastasis promoting protein S100A4 is increased in idiopathic inflammatory myopathies.","volume":"50","author":"Cerezo","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"R19-5-20210128","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/jclinpath-2011-200138","article-title":"Validity of internal expression of the major histocompatibility complex class I in the diagnosis of inflammatory myopathies.","volume":"65","author":"Salaroli","year":"2012","journal-title":"J Clin Pathol"},{"key":"R20-5-20210128","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1096\/fj.09-144782","article-title":"Effects of HMGB1 on in vitro responses of isolated muscle fibers and functional aspects in skeletal muscles of idiopathic inflammatory myopathies.","volume":"24","author":"Grundtman","year":"2010","journal-title":"FASEB J"},{"key":"R21-5-20210128","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1136\/ard.2008.091405","article-title":"Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies.","volume":"68","author":"Krystufkova","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R22-5-20210128","doi-asserted-by":"crossref","first-page":"6224","DOI":"10.4049\/jimmunol.168.12.6224","article-title":"IFN-stimulated gene 15 is synergistically activated through interactions between the myelocytelymphocyte-specific transcription factors, PU.1, IFN regulatory factor-8IFN consensus sequence binding protein, and IFN regulatory factor-4: characterization of a new subtype of IFN-stimulated response element.","volume":"168","author":"Meraro","year":"2002","journal-title":"J Immunol"},{"key":"R23-5-20210128","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ana.20464","article-title":"Interferon-alphabeta-mediated innate immune mechanisms in dermatomyositis.","volume":"57","author":"Greenberg","year":"2005","journal-title":"Ann Neurol"},{"key":"R24-5-20210128","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.clim.2006.05.011","article-title":"MxA gene expression in juvenile dermatomyositis peripheral blood mononuclear cells: association with muscle involvement.","volume":"120","author":"OConnor","year":"2006","journal-title":"Clin Immunol"},{"key":"R25-5-20210128","first-page":"103","article-title":"Diagnostic value of markers of muscle degeneration in sporadic inclusion body myositis.","volume":"30","author":"Dubourg","year":"2011","journal-title":"Acta Myol"},{"issue":"Suppl 2","key":"R26-5-20210128","doi-asserted-by":"crossref","first-page":"i82","DOI":"10.1136\/annrheumdis-2011-200587","article-title":"New approaches to the assessment and treatment of the idiopathic inflammatory myopathies.","volume":"71","author":"Miller","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R27-5-20210128","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/ar3531","article-title":"Type I interferon pathway in adult and juvenile dermatomyositis.","volume":"13","author":"Baechler","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"R28-5-20210128","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nri3210","article-title":"Interferon-inducible effector mechanisms in cell-autonomous immunity.","volume":"12","author":"Macmicking","year":"2012","journal-title":"Nat Rev Immunol"},{"issue":"Suppl 1","key":"R29-5-20210128","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/ar2886","article-title":"Type I interferon in organ-targeted autoimmune and inflammatory diseases.","volume":"12","author":"Crow","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"R30-5-20210128","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1212\/WNL.0b013e31821f440a","article-title":"Type I interferon and Toll-like receptor expression characterizes inflammatory myopathies.","volume":"76","author":"Cappelletti","year":"2011","journal-title":"Neurology"},{"key":"R31-5-20210128","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/ard.2010.139949","article-title":"Interferon beta is associated with type 1 interferon-inducible gene expression in dermatomyositis.","volume":"70","author":"Liao","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R32-5-20210128","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ana.21805","article-title":"Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophy.","volume":"67","author":"Salajegheh","year":"2010","journal-title":"Ann Neurol"},{"key":"R33-5-20210128","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1600-0560.2009.01443.x","article-title":"The phenotypic profile of dermatomyositis and lupus erythematosus: a comparative analysis.","volume":"37","author":"Magro","year":"2010","journal-title":"J Cutan Pathol"},{"key":"R34-5-20210128","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1002\/art.24936","article-title":"Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis.","volume":"60","author":"Bilgic","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R35-5-20210128","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejcb.2011.09.011","article-title":"Inflammatory response in human skeletal muscle cells: CXCL10 as a potential therapeutic target.","volume":"91","author":"Crescioli","year":"2012","journal-title":"Eur J Cell Biol"},{"key":"R36-5-20210128","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"R37-5-20210128","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/03009742.2010.517215","article-title":"Interleukin-17 and interleukin-23 in patients with polymyositis and dermatomyositis.","volume":"40","author":"Shen","year":"2011","journal-title":"Scand J Rheumatol"},{"key":"R38-5-20210128","first-page":"3660","article-title":"Toll-like receptors in rheumatic diseases: are we paying a high price for our defense against bugs FEBS L","volume":"585","author":"Santegoets","year":"2011","journal-title":"ett"},{"key":"R39-5-20210128","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1600-0560.2011.01854.x","article-title":"Prominent CD56 expression by damaged and regenerating muscle fibers in the skin.","volume":"39","author":"McKay","year":"2012","journal-title":"J Cutan Pathol"},{"key":"R40-5-20210128","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1093\/rheumatology\/keq151","article-title":"Idiopathic inflammatory myopathies, signified by distinctive peripheral cytokines, chemokines and the TNF family members B-cell activating factor and a proliferation inducing ligand.","volume":"49","author":"Szodoray","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"R41-5-20210128","doi-asserted-by":"crossref","first-page":"363","DOI":"10.4103\/0028-3886.43457","article-title":"Major histocompatibility complex class I expression can be used as a diagnostic tool to differentiate idiopathic inflammatory myopathies from dystrophies.","volume":"56","author":"Sundaram","year":"2008","journal-title":"Neurol India"},{"key":"R42-5-20210128","first-page":"605","article-title":"MHC Class I overexpression on muscles in early juvenile dermatomyositis.","volume":"31","author":"Li","year":"2004","journal-title":"J Rheumatol"},{"key":"R43-5-20210128","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1186\/ar2963","article-title":"Myofiber stress-response in myositis: parallel investigations on patients and experimental animal models of muscle regeneration and systemic inflammation.","volume":"12","author":"Vitadello","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"R44-5-20210128","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/ard.60.2.116","article-title":"Autoantibody profiles in the sera of European patients with myositis.","volume":"60","author":"Brouwer","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"R45-5-20210128","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.bbrc.2008.09.037","article-title":"Immunomodulatory effect of resistin in human dendritic cells stimulated with lipoteichoic acid from Staphylococcus aureus.","volume":"376","author":"Son","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"R46-5-20210128","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1136\/ard.2005.047704","article-title":"S100A4 is expressed at site of invasion in rheumatoid arthritis synovium and modulates production of matrix metalloproteinases.","volume":"65","author":"Senolt","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R47-5-20210128","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1093\/rheumatology\/kep316","article-title":"Metastasis-inducing S100A4 protein is associated with the disease activity of rheumatoid arthritis.","volume":"48","author":"Oslejskova","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"R48-5-20210128","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/jid.2009.206","article-title":"Significance of the S100A4 protein in psoriasis.","volume":"130","author":"Zibert","year":"2010","journal-title":"J Invest Dermatol"},{"key":"R49-5-20210128","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jns.2008.11.010","article-title":"Inflammatory myopathies with mitochondrial pathology and protein aggregates.","volume":"278","author":"Temiz","year":"2009","journal-title":"J Neurol Sci"},{"key":"R50-5-20210128","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/mus.21386","article-title":"Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis.","volume":"40","author":"Salajegheh","year":"2009","journal-title":"Muscle Nerve"},{"key":"R51-5-20210128","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1021\/pr800943t","article-title":"2-DE and LC-MSMS for a comparative proteomic analysis of BALf from subjects with different subsets of inflammatory myopathies.","volume":"8","author":"Passadore","year":"2009","journal-title":"J Proteome Res"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0b013e3283585731","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T21:22:45Z","timestamp":1714425765000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201211000-00005"}},"subtitle":["biomarkers for idiopathic inflammatory myopathies"],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e3283585731","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}